NCT05635734
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05635734
Title Azeliragon and Chemoradiotherapy in Newly Diagnosed Glioblastoma
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Cantex Pharmaceuticals
Indications
Therapies
Age Groups: senior | adult
Covered Countries ESP

Facility Status City State Zip Country Details
Hospital del Mar Barcelona Barcelona 08003 Spain Details
Hospital Clínic de Barcelona Barcelona Barcelona 08036 Spain Details
Hospital Universitario Ramon y Cajal Madrid Madrid 28034 Spain Details
Hospital Universitario 12 de Octubre Madrid Madrid 28041 Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field